These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18840677)

  • 1. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.
    Carbone DL; Popichak KA; Moreno JA; Safe S; Tjalkens RB
    Mol Pharmacol; 2009 Jan; 75(1):35-43. PubMed ID: 18840677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells.
    Tjalkens RB; Liu X; Mohl B; Wright T; Moreno JA; Carbone DL; Safe S
    J Neurosci Res; 2008 Feb; 86(3):618-29. PubMed ID: 18041089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons.
    Miller JA; Trout BR; Sullivan KA; Bialecki RA; Roberts RA; Tjalkens RB
    J Neurosci Res; 2011 Mar; 89(3):406-17. PubMed ID: 21259327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.
    De Miranda BR; Popichak KA; Hammond SL; Jorgensen BA; Phillips AT; Safe S; Tjalkens RB
    Mol Pharmacol; 2015 Jun; 87(6):1021-34. PubMed ID: 25858541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
    De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
    Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines.
    Liu X; Buffington JA; Tjalkens RB
    Brain Res Mol Brain Res; 2005 Nov; 141(1):39-47. PubMed ID: 16168523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.
    Lee KM; Lee Y; Chun HJ; Kim AH; Kim JY; Lee JY; Ishigami A; Lee J
    J Neurosci Res; 2016 Oct; 94(10):865-78. PubMed ID: 27265894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(
    Hammond SL; Popichak KA; Li X; Hunt LG; Richman EH; Damale PU; Chong EKP; Backos DS; Safe S; Tjalkens RB
    J Pharmacol Exp Ther; 2018 Jun; 365(3):636-651. PubMed ID: 29626009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice.
    Lecca D; Nevin DK; Mulas G; Casu MA; Diana A; Rossi D; Sacchetti G; Fayne D; Carta AR
    Neuroscience; 2015 Aug; 302():23-35. PubMed ID: 25907448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.
    Dehmer T; Heneka MT; Sastre M; Dichgans J; Schulz JB
    J Neurochem; 2004 Jan; 88(2):494-501. PubMed ID: 14690537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.
    De Miranda BR; Miller JA; Hansen RJ; Lunghofer PJ; Safe S; Gustafson DL; Colagiovanni D; Tjalkens RB
    J Pharmacol Exp Ther; 2013 Apr; 345(1):125-38. PubMed ID: 23318470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene deletion of nos2 protects against manganese-induced neurological dysfunction in juvenile mice.
    Streifel KM; Moreno JA; Hanneman WH; Legare ME; Tjalkens RB
    Toxicol Sci; 2012 Mar; 126(1):183-92. PubMed ID: 22174044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Chalimoniuk M; Lukacova N; Marsala J; Langfort J
    Neuroscience; 2006 Aug; 141(2):1033-1046. PubMed ID: 16716528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    López A; Ortiz F; Doerrier C; Venegas C; Fernández-Ortiz M; Aranda P; Díaz-Casado ME; Fernández-Gil B; Barriocanal-Casado E; Escames G; López LC; Acuña-Castroviejo D
    PLoS One; 2017; 12(8):e0183090. PubMed ID: 28800639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.